Risk factors for cardiovascular events in hospitalized patients with community-acquired pneumonia

International Journal of Infectious Diseases

Volumn 17, Issue 12, 2013, Pages

  Griffin, Allen T ^a   Wiemken, Timothy L ^a   Arnold, Forest W ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cardiovascular risk factors; Community acquired pneumonia

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MACROLIDE; QUINOLONE; WARFARIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG USE; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; KLEBSIELLA PNEUMONIAE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; STAPHYLOCOCCUS AUREUS;

CARDIOVASCULAR RISK FACTORS; COMMUNITY-ACQUIRED PNEUMONIA;

ADULT; AGED; CARDIOVASCULAR DISEASES; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PNEUMONIA; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84888440015     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.07.005     Document Type: Article

References (24)

1. Jasti H., Mortensen E.M., Obrosky D.S., Kapoor W.N., Fine M.J. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia. Clin Infect Dis 2008, 46:550-556.
2. Corrales-Medina V.F., Musher D.M., Wells G.A., Chirinos J.A., Chen L., Fine M.J. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation 2012, 125:773-781.
3. Ramirez J., Aliberti S., Mirsaeidi M., Peyrani P., Filardo G., Amir A., et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis 2008, 47:182-187.
4. Perry T.W., Pugh M.J., Waterer G.W., Nakashima B., Orihuela C.J., Copeland L.A., et al. Incidence of cardiovascular events after hospital admission for pneumonia. Am J Med 2011, 124:244-251.
5. Musher D.M., Rueda A.M., Kaka A.S., Mapara S.M. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis 2007, 45:158-165.
6. Viasus D., Garcia-Vidal C., Manresa F., Dorca J., Gudiol F., Carratalà J. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia. J Infect 2013, 66:27-33.
7. Becker T., Moldoveanu A., Cukierman T., Gerstein H.C. Clinical outcomes associated with the use of subcutaneous insulin-by-glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia. Diabetes Res Clin Pract 2007, 78:392-397.
8. Mortensen E.M., Nakashima B., Cornell J., Copeland L.A., Pugh M.J., Anzueto A., et al. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis 2012, 55:1466-1473.
9. Fine M.J., Auble T.E., Yealy D.M., Hanusa B.H., Weissfeld L.A., Singer D.E. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997, 336:243-250.
10. Bursac Z., Gauss C.H., Williams D.K., Hosmer D.W. Purposeful selection of variables in logistic regression. Source Code Biol Med 2008, 3:17.
11. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2008. Available at: (accessed November 22, 2012). http://www.r-project.org/.
12. Harrell F.E. Regression modeling strategies 2001, Springer Verlag, New York.
13. Campbell L.A., Yaraei K., Van Lenten B., Chait A., Blessing E., Kuo C.C., et al. The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis. Microbes Infect 2010, 12:598-606.
14. Hikita H., Kuroda S., Oosaka Y., Kawaguchi N., Nakashima E., Sugiyama T., et al. Impact of statin use before the onset of acute myocardial infarction on coronary plaque morphology of the culprit lesion. Angiology 2012, 64:375-378.
15. Lee C.S., Yi E.H., Lee J.K., Won C., Lee Y.J., Shin M.K., et al. Simvastatin suppresses RANTES-mediated neutrophilia in poly I:C-induced pneumonia. Eur Respir J 2012, 41:1147-1156.
16. Deniz O., Tozkoparan E., Yaman H., Cakir E., Gumus S., Ozcan O., et al. Serum HDL-C levels, log (TG/HDL-C) values and serum total cholesterol/HDL-C ratios significantly correlate with radiological extent of disease in patients with community-acquired pneumonia. Clin Biochem 2006, 39:287-292.
17. Issac T.T., Dokainish H., Lakkis N.M. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol 2007, 50:2021-2028.
18. Mishra A., Friedman H.S., Sinha A.K. The effects of erythromycin on the electrocardiogram. Chest 1999, 115:983-986.
19. Beigelman A., Mikols C.L., Gunsten S.P., Cannon C.L., Brody S.L., Walter M.J. Azithromycin attenuates airway inflammation in a mouse model of viral bronchiolitis. Respir Res 2010, 11:90.
20. Iriz E., Cirak M.Y., Engin E.D., Zor M.H., Erer D., Imren Y., et al. Effects of atypical pneumonia agents on progression of atherosclerosis and acute coronary syndrome. Acta Cardiol 2007, 62:593-598.
21. Suda K., Eom J., Jaw J.E., Mui T., Bai N., Or C., et al. Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin. J Appl Physiol 2011, 111:1118-1124.
22. Ray W.A., Murray K.T., Hall K., Arbogast P.G., Stein C.M. Azithromycin and the risk of cardiovascular death. N Engl J Med 2012, 366:1881-1890.
23. Schembri S., Williamson P.A., Short P.M., Singanayagam A., Akram A., Taylor J., et al. Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies. BMJ 2013, 346:f1235.
24. Svanström H., Pasternak B., Hviid A. Use of azithromycin and death from cardiovascular causes. N Engl J Med 2013, 368:1704-1712.